中国报纸中的痴呆症知识 (2005-2020):一个主题建模分析
Lin Chen1, Felicia F Tian2, Yu Fu2
1Department of Social Work, Fudan University.
Journal of aging & social policy
|May 7, 2024
概括
中国的报纸越来越多地报道了痴呆症护理,但仍然对衰老有耻辱感. 需要进行媒体宣传,以提高公众的理解,并创造一个包括痴呆症的社会.
科学领域:
- 公共卫生沟通公共卫生沟通
- 媒体研究 媒体研究
- 老年学是一门学科.
背景情况:
- 新闻通过政策传播来塑造公众对痴呆症的理解.
- 了解媒体描绘对于公共卫生倡议至关重要.
研究的目的:
- 分析中国报纸在2005年至2020年期间对痴呆症的报道.
- 确定痴呆症知识和公众认知的趋势.
- 评估媒体在痴呆症污名化中的作用.
主要方法:
- 主题建模 (隐性迪里克莱特分配 - LDA) 应用于来自中国大陆45家报纸的12719篇文章.
- 分析涵盖了2005-2020年期间,使用了WiseNews数据库.
- 确定了六个普遍的主题:生活方式,社区,研究,媒体,护理和制药.
主要成果:
- 痴呆症护理文章增加,而生活方式建议在2005-2020年间下降.
- 新闻经常将痴呆与老年联系在一起,通过偏见的语言使耻辱感延续下去.
- 覆盖范围涵盖了痴呆症知识的关键维度.
结论:
- 媒体的描述显著影响着公众对痴呆症的理解和看法.
- 需要有针对性的大众媒体活动,以提高中国的痴呆素养.
- 促进一个包括痴呆症的社会需要解决媒体相关的耻辱.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.中国中国中国中国.痴呆症 痴呆症是一种痴呆症.痴呆症知识知识知识隐藏的迪里克莱特分配.大众媒体就是大众媒体.新闻报纸报纸报纸报纸报纸报纸主题建模主题建模更多相关视频
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
1.4K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.8K
相关概念视频
Dementia
112
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
112
Alzheimer's Disease: Overview
467
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
467
Alzheimer's Disease: Treatment
181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181
